Below is a special message from our valued partners and today's top market news.
Do you have any of these 5 overvalued stocks? - Ad
By taking advantage of timing, you can position yourself for a massive windfall or avoid potential losses. Today we look at the top 5 overvalued stocks that analysts expect to drop in price.
The Elon Musk-led mega-EV company Tesla Inc (NASDAQ: TSLA) announced on Aug. 4 its intention to split its stock just two years after completing another stock split. With the 3-1 split just a week away, here's what you need to know about it. More Info...
He predicted the 2020 crash a month before it happened... He predicted this year's collapse back in January... And now, he's issuing a brand-new warning -- along with a unique solution. Details here.
Bank of America economists Anna Zhou and Taylor Browley released a note on Aug. 16 regarding the analyst firm's small business checkpoint. More Info...
Big Auto has just been put "on notice." GM, Ford, Toyota, BMW, Honda, Nissan, and Volkswagen are scrambling to get this new battery technology inside their vehicles. But the real story is the tiny company with key patents to this technology. See the $2 stock leading the way
Morgan Stanley boosted the price target for Meta Platforms, Inc. (NASDAQ: META) from $280 to $225. Meta shares fell 2.1% to $171.01 in pre-market trading. More Info...
It trades under a secret name... for just $5. But thanks to a developing situation involving Apple, 50,000 American jobs and $10 billion... this may soon be the most talked about stock in America. More Info...
Bed Bath & Beyond Inc (NASDAQ: BBBY) shares are tanking in Thursday's after-hours session after a new SEC filing confirmed that GameStop Corp (NYSE: GME) chair Ryan Cohen sold his stake i More Info...
U.S. stock futures traded lower this morning on Friday after closing slightly higher in the previous session. Investors, meanwhile, focused on some notable insider trades. More Info...
Learn a profitable newbie-friendly crypto loophole that works no matter if markets are up or down. Register for our free "Loophole" strategy training today. Register Here
The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics' (NASDAQ: AXSM) lead asset AUVELITY (dextromethorphan HBr -bupropion HCl) extended-release tablets for the treatment of major depressive disorder (MDD) in adults. More Info...
New York continues making progress in cannabis legalization. By green-lighting emergency lab testing regulations and opening the application process for testing facilities, the New York State Cannabis Control Board (CCB) recently moved closer to launching recreational sales and opening adult-use stores in the state. More Info...
Applied Materials, Inc. (NASDAQ: AMAT) reported better-than-expected results for its third quarter. The company also said it sees Q4 adjusted earnings of $1.82 to $2.18 per share on sales of $6.25 billion to $7.05 billion. More Info...
Build a portfolio that's tailored to their particular retirement goals with our free report on the top stock under $10 for 2022! Get Today's Free Stock Report Here
The US Food and Drug Administration (FDA) has accepted for filing Krystal Biotech's (NASDAQ: KRYS) Biologics License Application (BLA) for its lead candidate B-VEC in the treatment of patients with dystrophic epidermolysis bullosa (DEB). More Info...
What are the markets reacting to during the pandemic? This is the latest stock on the rise. More Info...
Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. This is not individualized investment management. This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.
By taking advantage of timing, you can position yourself for a massive windfall or avoid potential losses. Today we look at the top 5 overvalued stocks that analysts expect to drop in price. 
Post a Comment
Post a Comment